Tetrazepam

DB13324

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 288.772
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

668 Data
Buprenorphine Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Hydrocodone Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Magnesium sulfate The therapeutic efficacy of Tetrazepam can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Tetrazepam may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Mirtazapine Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Orphenadrine Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Pramipexole Tetrazepam may increase the sedative activities of Pramipexole.
Ropinirole Tetrazepam may increase the sedative activities of Ropinirole.
Rotigotine Tetrazepam may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Tetrazepam.
Sodium oxybate Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Thalidomide Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Tetrazepam.
Ethanol Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Fluvoxamine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Tetrazepam is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Tetrazepam is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Tetrazepam is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Tetrazepam is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Tetrazepam is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Tetrazepam is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Tetrazepam is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Tetrazepam is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Tetrazepam is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Tetrazepam.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Tetrazepam.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Tetrazepam.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Tetrazepam.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Tetrazepam.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Tetrazepam.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Tetrazepam.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Tetrazepam.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Tetrazepam.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Tetrazepam.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Tetrazepam.
Zopiclone The risk or severity of adverse effects can be increased when Tetrazepam is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Tetrazepam.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Tetrazepam.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Tetrazepam.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Tetrazepam.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Tetrazepam.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Tetrazepam.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Tetrazepam.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Tetrazepam.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Tetrazepam.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Tetrazepam.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Tetrazepam.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Tetrazepam.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Tetrazepam.
Methysergide The risk or severity of CNS depression can be increased when Methysergide is combined with Tetrazepam.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Tetrazepam.
Phenytoin The risk or severity of CNS depression can be increased when Phenytoin is combined with Tetrazepam.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Tetrazepam.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Tetrazepam.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tetrazepam.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Tetrazepam.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Tetrazepam.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Tetrazepam.
Pentobarbital The risk or severity of CNS depression can be increased when Pentobarbital is combined with Tetrazepam.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Tetrazepam.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tetrazepam.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Tetrazepam.
Dihydroergotamine The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Tetrazepam.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Tetrazepam.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tetrazepam.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Tetrazepam.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Tetrazepam.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Tetrazepam.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Tetrazepam.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Tetrazepam.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Tetrazepam.
Clozapine The risk or severity of CNS depression can be increased when Clozapine is combined with Tetrazepam.
Meprobamate The risk or severity of CNS depression can be increased when Meprobamate is combined with Tetrazepam.
Thiethylperazine The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Tetrazepam.
Palonosetron The risk or severity of CNS depression can be increased when Palonosetron is combined with Tetrazepam.
Sulpiride The risk or severity of CNS depression can be increased when Sulpiride is combined with Tetrazepam.
Alprazolam The risk or severity of CNS depression can be increased when Alprazolam is combined with Tetrazepam.
Dexbrompheniramine The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Tetrazepam.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul